Provider
Interleukin-13 (IL-13) Antagonist - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Nov 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2025
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2025
Step Therapy, Quantity Limit
Program effective Date: May 01, 2025
Step Therapy, Quantity Limit
Program effective Date: May 01, 2025
Quantity Limit
Program effective Date: Jun 01, 2025
Step Therapy, Quantity Limit
Program effective Date: Oct 15, 2025